ADVANCED HODGKIN LYMPHOMA
Clinical trials for ADVANCED HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for ADVANCED HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test may guide safer chemo for hodgkin lymphoma patients
Disease control Recruiting nowThis phase 2 trial is testing whether a blood test that measures tumor DNA (ctDNA) can help doctors safely reduce the amount of chemotherapy for people with advanced Hodgkin lymphoma. After two cycles of standard chemo, patients with undetectable ctDNA may receive fewer total cyc…
Matched conditions: ADVANCED HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New shorter chemo combo shows promise for hodgkin lymphoma
Disease control Recruiting nowThis phase 2 trial is testing a shortened course of a drug combination called BrECADD for people with advanced Hodgkin lymphoma. The goal is to see if a shorter treatment can still control the cancer while reducing side effects. About 48 adults aged 18 to 60 will receive up to fo…
Matched conditions: ADVANCED HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New combo therapy aims to outsmart hodgkin lymphoma
Disease control Recruiting nowThis study tests a new way to treat advanced Hodgkin lymphoma by combining the immunotherapy drug nivolumab with chemotherapy. Doctors use PET scans early in treatment to see how well it's working and adjust therapy accordingly. The goal is to improve outcomes while reducing side…
Matched conditions: ADVANCED HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: National Research Center for Hematology, Russia • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC